Ming Clinton Yeung

This inventor holds 30 USPTO granted patents and 15 published patent applications, plus 3 CIPO patents and 13 EPO patents. Top assignees: Abbott Laboratories Corporation, Galapagos Nv, Abbvie S.a.r.l.. Active years: 1997-2021.

USPTO Granted Patents = 30 (Patent Applications = 15)

% Patents Active = 70.0

CIPO Patents = 3 (Patent Applications = 11)

EPO Patents = 13 (Patent Applications = 15)

Average Co-Inventor Count = 10.6

ph-index = 6

Forward Citations = 169(Granted Patents)

Company Filing History:

13 out of 4,186

Abbott Laboratories Corporation

where one patent can have more than one assignee

Years Active: 1997-2021

Loading Chart...

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10988454 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use (2021-04-27),

2. 10981890 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use (2021-04-20),

3. 10844042 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use (2020-11-24),

4. 10844041 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use (2020-11-24),

5. 10829473 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use (2020-11-10),

6. 10428017 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use (2019-10-01),

7. 10399940 - Substituted pyrrolidines and methods of use (2019-09-03),

8. 10118916 - Modulators of cystic fibrosis transmembrane conductance regulator protein (2018-11-06),

9. 9981910 - Substituted pyrrolidines and methods of use (2018-05-29),

10. 9840513 - Substituted tricyclics and method of use (2017-12-12),

11. 9642831 - Substituted chromanes and method of use (2017-05-09),

12. 9567322 - Substituted tetrahydropyrans and method of use (2017-02-14),

13. 8937041 - Macrocyclic hepatitis C serine protease inhibitors (2015-01-20),

14. 8796470 - Substituted octahydrocyclopenta[c]pyrroles as calcium channel modulators (2014-08-05),

15. 8691865 - Substituted octahydrocyclopenta[C]pyrrol-4-amines as calcium channel blockers (2014-04-08),

Title: The Innovative Mind of Ming Clinton Yeung

Introduction: Ming Clinton Yeung, a talented inventor based in Grayslake, IL (US), is known for his groundbreaking contributions to the field of technology and innovation. With a passion for creating solutions to complex problems, Yeung has made a significant impact in the world of patents and inventions.

Latest Patents: Yeung's latest patents showcase his ingenuity and forward-thinking approach to innovation. His recent inventions focus on improving efficiency in renewable energy systems and enhancing user experience in the realm of smart devices.

Career Highlights: Throughout his career, Ming Clinton Yeung has demonstrated a remarkable ability to transform ideas into tangible inventions. His work has been recognized for its creativity and practicality, earning him a reputation as a leading innovator in his field.

Collaborations: Yeung has collaborated with top research institutions and technology companies to bring his inventions to life. His partnerships have led to the development of cutting-edge products that have revolutionized various industries.

Conclusion: Ming Clinton Yeung's dedication to innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of inventors. His passion for creating solutions that make a difference continues to inspire others in the field of technology and beyond.